京新药业：公司的盐酸卡利拉嗪已申报待批准

Core Viewpoint - Jingxin Pharmaceutical (002020.SZ) has submitted its application for the approval of its drug, Calcitonin Salts, which is currently pending approval [1] Company Summary - Jingxin Pharmaceutical is actively pursuing the approval of its hydrochloride formulation of Calcitonin Salts, indicating a strategic move to expand its product offerings in the pharmaceutical market [1]